BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12883652)

  • 1. Nucleotides in both donor and acceptor splice sites are responsible for choice in NAGNAG tandem splice sites.
    Hujová P; Souček P; Radová L; Kramárek M; Kováčová T; Freiberger T
    Cell Mol Life Sci; 2021 Nov; 78(21-22):6979-6993. PubMed ID: 34596691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-EST-based method for exon-skipping prediction.
    Sorek R; Shemesh R; Cohen Y; Basechess O; Ast G; Shamir R
    Genome Res; 2004 Aug; 14(8):1617-23. PubMed ID: 15289480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-EST based prediction of exon skipping and intron retention events using Pfam information.
    Hiller M; Huse K; Platzer M; Backofen R
    Nucleic Acids Res; 2005; 33(17):5611-21. PubMed ID: 16204458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splice site recognition - deciphering Exon-Intron transitions for genetic insights using Enhanced integrated Block-Level gated LSTM model.
    Sha M; Parveen Rahamathulla M
    Gene; 2024 Jul; 915():148429. PubMed ID: 38575098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
    Thomassen M; Mesman RLS; Hansen TVO; Menendez M; Rossing M; Esteban-Sánchez A; Tudini E; Törngren T; Parsons MT; Pedersen IS; Teo SH; Kruse TA; Møller P; Borg Å; Jensen UB; Christensen LL; Singer CF; Muhr D; Santamarina M; Brandao R; Andresen BS; Feng BJ; Canson D; Richardson ME; Karam R; Pesaran T; LaDuca H; Conner BR; Abualkheir N; Hoang L; Calléja FMGR; Andrews L; James PA; Bunyan D; Hamblett A; Radice P; Goldgar DE; Walker LC; Engel C; Claes KBM; Macháčková E; Baralle D; Viel A; Wappenschmidt B; Lazaro C; Vega A; ; Vreeswijk MPG; de la Hoya M; Spurdle AB
    Hum Mutat; 2022 Dec; 43(12):1921-1944. PubMed ID: 35979650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification of pseudo-exon activation events in personal genome and transcriptome data.
    Sakaguchi N; Suyama M
    RNA Biol; 2021 Mar; 18(3):382-390. PubMed ID: 32865117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RCDA: a highly sensitive and specific alternatively spliced transcript assembly tool featuring upstream consecutive exon structures.
    Sturgeon XH; Gardiner KJ
    Genomics; 2012 Dec; 100(6):357-62. PubMed ID: 22971325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis reveals splicing biomarkers for tuberculosis progression and prognosis.
    Lai H; Lyu M; Ruan H; Liu Y; Liu T; Lei S; Xiao Y; Zhang S; Ying B
    Comput Biol Med; 2024 Mar; 171():108187. PubMed ID: 38402840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaTCH: Calculating transcript complexity of human genes.
    Basu K; Dey A; Kiran M
    MethodsX; 2024 Jun; 12():102697. PubMed ID: 38638454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative imaging of single mRNA splice variants in living cells.
    Lee K; Cui Y; Lee LP; Irudayaraj J
    Nat Nanotechnol; 2014 Jun; 9(6):474-80. PubMed ID: 24747838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
    Cangelosi D; Muselli M; Parodi S; Blengio F; Becherini P; Versteeg R; Conte M; Varesio L
    BMC Bioinformatics; 2014; 15 Suppl 5(Suppl 5):S4. PubMed ID: 25078098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.
    Albini A; Rosano C; Angelini G; Amaro A; Esposito AI; Maramotti S; Noonan DM; Pfeffer U
    Curr Med Chem; 2014; 21(9):1129-45. PubMed ID: 24304271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.
    Cangelosi D; Blengio F; Versteeg R; Eggert A; Garaventa A; Gambini C; Conte M; Eva A; Muselli M; Varesio L
    BMC Bioinformatics; 2013; 14 Suppl 7(Suppl 7):S12. PubMed ID: 23815266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of estrogen receptor isoforms and variants in breast cancer cell lines.
    Al-Bader M; Ford C; Al-Ayadhy B; Francis I
    Exp Ther Med; 2011 May; 2(3):537-544. PubMed ID: 22977537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptors and the regulation of neural stress responses.
    Handa RJ; Mani SK; Uht RM
    Neuroendocrinology; 2012; 96(2):111-8. PubMed ID: 22538291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel transcript variants of estrogen receptor α, β and progesterone receptor gene in human endometrium.
    Springwald A; Lattrich C; Skrzypczak M; Goerse R; Ortmann O; Treeck O
    Endocrine; 2010 Jun; 37(3):415-24. PubMed ID: 20960162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of transcription factors' genes: beyond the increase of proteome diversity.
    Talavera D; Orozco M; de la Cruz X
    Comp Funct Genomics; 2009; 2009():905894. PubMed ID: 19609452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia.
    Wong J; Weickert CS
    J Biol Chem; 2009 Jul; 284(28):18824-32. PubMed ID: 19439407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of the human estrogen receptor alpha primary transcript: mechanisms of exon skipping.
    Ferro P; Forlani A; Muselli M; Pfeffer U
    Int J Mol Med; 2003 Sep; 12(3):355-63. PubMed ID: 12883652
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.